Journal of Stroke & Cerebrovascular Diseases
Volume 16, Issue 4 , Pages 145-152 , July 2007

Lack of Association Between Infectious Burden and Carotid Atherosclerosis in Japanese Patients

  • Noriko Hagiwara, MD

      Affiliations

    • Department of Cerebrovascular Disease, Cerebrovascular Center and Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
    • Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
    • Corresponding Author InformationAddress reprint requests to Noriko Hagiwara, MD, Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
    • ,
  • Kazunori Toyoda, MD, PhD

      Affiliations

    • Department of Cerebrovascular Disease, Cerebrovascular Center and Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
    • ,
  • Tooru Inoue, MD, PhD

      Affiliations

    • Department of Neurosurgery, Cerebrovascular Center and Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
    • ,
  • Hirofumi Shimada, MT

      Affiliations

    • Medical Laboratory, Cerebrovascular Center and Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
    • ,
  • Setsuro Ibayashi, MD, PhD

      Affiliations

    • Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
    • ,
  • Mitsuo Iida, MD, PhD

      Affiliations

    • Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
    • ,
  • Yasushi Okada, MD, PhD

      Affiliations

    • Department of Cerebrovascular Disease, Cerebrovascular Center and Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan

Received 1 November 2006 ,Revised 26 January 2007 ,Accepted 14 February 2007.

References 

  1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115–126
  2. Espinola-Klein C, Rupprecht HJ, Blankenberg S, et al. Are morphological or functional changes in the carotid artery wall associated with Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, or herpes simplex virus infection?. Stroke. 2000;31:2127–2133
  3. Folsom AR, Nieto FJ, Sorlie P, et al. Helicobacter pylori seropositivity and coronary heart disease incidence. Circulation. 1998;98:845–850
  4. Melnick SL, Shahar E, Folsom AR, et al. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis (Atherosclerosis Risk in Communities (ARIC) Study Investigators). Am J Med. 1993;95:499–504
  5. Prager M, Turel Z, Speidl WS, et al. Chlamydia pneumoniae in carotid artery atherosclerosis: a comparison of its presence in atherosclerotic plaque, healthy vessels, and circulating leukocytes from the same individuals. Stroke. 2002;33:2756–2761
  6. Saikku P, Leinonen M, Mattila K, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;2:983–986
  7. Sorlie PD, Adam E, Melnick SL, et al. Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC Study. J Med Virol. 1994;42:33–37
  8. Bishara J, Pitlik S, Kazakov A, et al. Failure to detect Chlamydia pneumoniae by cell culture and polymerase chain reaction in major arteries of 93 patients with atherosclerosis. Eur J Clin Microbiol Infect Dis. 2003;22:300–302
  9. Paterson DL, Hall J, Rasmussen SJ, et al. Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients. Pathology. 1998;30:169–172
  10. Weiss SM, Roblin PM, Gaydos CA, et al. Failure to detect Chlamydia pneumoniae in coronary atheromatous of patients undergoing atherectomy. J Infect Dis. 1996;173:957–962
  11. Epstein SE, Zhu J, Burnett MS, et al. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol. 2000;20:1417–1420
  12. Espinola-Klein C, Rupprecht HJ, Blankenberg S, et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation. 2002;105:15–21
  13. Mizooka M, Ishikawa S JMS Cohort Study Group. Prevalence of Chlamydia pneumoniae in Japanese rural districts: association of smoking and physical activity with Chlamydia pneumoniae seropositivity. Intern Med. 2003;42:960–966
  14. Hirashima Y, Kuwayama N, Kubo M, et al. Chlamydia pneumoniae infection is not involved in carotid artery stenosis. Atherosclerosis. 2002;163:165–168
  15. Maeda N, Sawayama Y, Tatsukawa M, et al. Chlamydia pneumoniae seropositivity and early carotid atherosclerosis in a suburban Japanese population. Atherosclerosis. 2002;164:313–319
  16. Ouchi K, Fujii B, Kanamoto Y, et al. Chlamydia pneumoniae in coronary and iliac arteries of Japanese patients with atherosclerotic cardiovascular diseases. J Med Microbiol. 1998;47:907–913
  17. Yamashita K, Ouchi K, Shirai M, et al. Distribution of Chlamydia pneumoniae infection in the atherosclerotic carotid artery. Stroke. 1998;29:773–778
  18. Fujimoto S, Toyoda K, Inoue T, et al. Diagnostic impact of transcranial color-coded real-time sonography with echo contrast agents for hyperperfusion syndrome after carotid endarterectomy. Stroke. 2004;35:1852–1856
  19. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Steering CommitteeNational Institute of Neurological Disorders and Stroke and Trauma Division. Clinical alert: benefit of carotid endarterectomy for patients with high-grade stenosis of the internal carotid artery. Stroke. 1991;22:816–817
  20. De Bray JM, Baud JM, Dauzat M. Consensus concerning the morphology and the risk of carotid plaques. Cerebrovasc Dis. 1997;7:289–296
  21. The Surgeon General’s report on the health benefits of smoking cessation: executive summary. MMWR Recomm Rep. 1990;39:1–12
  22. Kanamoto Y, Iijima Y, Miyashita N, et al. Antigenic characterization of Chlamydia pneumoniae isolated in Hiroshima, Japan. Microbiol Immunol. 1993;37:495–498
  23. Kishimoto T, Kubota Y, Matsushima T, et al. Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 2 (Studies on clinical usefulness and serological diagnostic standards). Kansenshogaku Zasshi. 1996;70:821–829
  24. Numazaki K, Ikebe T, Chiba S. Detection of serum antibodies against Chlamydia pneumoniae by ELISA. FEMS Immunol Med Microbiol. 1996;14:179–183
  25. Cao M, Xiao X, Egbert B, et al. Rapid detection of cutaneous herpes simplex virus infection with the polymerase chain reaction. J Invest Dermatol. 1989;92:391–392
  26. Kawamata O, Yoshida H, Hirota K, et al. Nested-polymerase chain reaction for the detection of Helicobacter pylori infection with novel primers designed by sequence analysis of urease a gene in clinically isolated bacterial strains. Biochem Biophys Res Commun. 1996;219:266–272
  27. Olive DM, Simsek M, Al-Mufti S. Polymerase chain reaction for detection of human cytomegalovirus. J Clin Microbiol. 1989;27:1238–1242
  28. Campbell LA, Melgosa MP, Hamilton DJ, et al. Detection of Chlamydia pneumoniae by polymerase chain reaction. J Clin Microbiol. 1992;30:434–439
  29. LaBiche R, Koziol D, Quinn TC, et al. Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque. Stroke. 2001;32:855–860
  30. Farsak B, Yildirir A, Akyon Y, et al. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J Clin Microbiol. 2000;38:4408–4411
  31. Kuo CC, Shor A, Campbell LA, et al. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 1993;167:841–849
  32. Thomas M, Wong Y, Thomas D, et al. Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (Stary grading) of associated atherosclerotic plaque. Circulation. 1999;99:2733–2736
  33. Hendrix MG, Salimans MM, van Boven CP, et al. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol. 1990;136:23–28
  34. Ibrahim AI, Obeid MT, Jouma MJ, et al. Detection of herpes simplex virus, cytomegalovirus and Epstein-Barr virus DNA in atherosclerotic plaques and in unaffected bypass grafts. J Clin Virol. 2005;32:29–32
  35. Shi Y, Tokunaga O. Herpesvirus (HSV-1, EBV, and CMV) infections in atherosclerotic compared with non-atherosclerotic aortic tissue. Pathol Int. 2002;52:31–39
  36. Kowalski M, Rees W, Konturek PC, et al. Detection of Helicobacter pylori–specific DNA in human atheromatous coronary arteries and its association to prior myocardial infarction and unstable angina. Dig Liver Dis. 2002;34:398–402
  37. Chiu B, Viira E, Tucker W, et al. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation. 1997;96:2144–2148
  38. Jander S, Sitzer M, Schumann R, et al. Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization. Stroke. 1998;29:1625–1630
  39. Key NS, Vercellotti GM, Winkelmann JC, et al. Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proc Natl Acad Sci U S A. 1990;87:7095–7099

 Supported in part by a Research Grant for Cardiovascular Diseases (15C-1) from the Japanese Ministry of Health, Labor, and Welfare.

PII: S1052-3057(07)00035-3

doi: 10.1016/j.jstrokecerebrovasdis.2007.02.001

Journal of Stroke & Cerebrovascular Diseases
Volume 16, Issue 4 , Pages 145-152 , July 2007

Article Tools

* Image Usage & Resolution